A Look At GE HealthCare Technologies (GEHC) Valuation After New Edge AI Partnership With NXP

GE HealthCare Technologies (GEHC) is back in focus after announcing a collaboration with NXP Semiconductors to apply edge AI to anesthesia delivery and neonatal monitoring, with concept systems showcased at CES 2026.

See our latest analysis for GE HealthCare Technologies.

The NXP partnership and the upcoming February results arrive after a strong 90-day share price return of 20.77% and a three year total shareholder return of 31.22%. However, the one year total shareholder return is slightly negative at 0.40%, which suggests recent momentum has picked up from a softer patch.

If this kind of AI driven healthcare story interests you, it can be worth scanning the wider sector and seeing which healthcare stocks are catching attention right now.

With GE HealthCare trading at $85.76 against an analyst price target of $91.20 and an estimated intrinsic discount of 38.67%, is there still a buying opportunity here, or is the market already pricing in future growth?

With the narrative fair value sitting at about $89.22 against the latest close of $85.76, the model is signaling modest upside and leaning on a detailed earnings roadmap to get there.

The pipeline of new high-impact products, like Radiopharmaceuticals, Total Body PET, and Photon Counting CT, is anticipated to drive future revenue growth and potentially improve margins.

Read the complete narrative.

Want to see what underpins that premium on future earnings? This narrative leans heavily on measured revenue growth, firm profit margins, and a forward earnings multiple that is not stretched by sector standards. The real interest is how those elements combine to justify today’s fair value line.

Result: Fair Value of $89.22 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, the picture is mixed, with tariff and China related regulatory risks, plus competitive pressure in advanced imaging, all capable of denting that earnings roadmap.

Find out about the key risks to this GE HealthCare Technologies narrative.

If you see the story differently, or want to test your own assumptions against the data, you can build a custom view in just a few minutes, starting with Do it your way.

A great starting point for your GE HealthCare Technologies research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

If GE HealthCare has your attention, do not stop here. The Simply Wall St screener can surface other focused ideas that might fit your style.